Former IBM Research engineers and Chronus Health founders — we take diagnostic platforms from bench to clinical validation. Initial call is 30 minutes and free.
Combined IVD experience
Diagnostic platforms developed
Issued US patents
Founders' Track Record
Whether you're pre-seed or post-market, we scale our engagement to where you are.
From napkin sketch to first prototype — we move fast without cutting corners on science.
Expanding into new assay categories or troubleshooting existing platforms — without building a full in-house team.
Technical diligence on diagnostic assets. We speak both scientist and investor — and tell you what the data actually means.
Translating research-grade results into commercially viable diagnostic products with a clear path to clinical validation.
The Team Behind the Work
Ashish V. Jagtiani, Ph.D.
Founder & CTO, Chronus Health · Former IBM Research · 6 US Patents
Rajinder Bhatia, Ph.D.
25+ years IVD assay chemistry · Xip Diagnostics · BD Biosciences · 4 US Patents
Every engagement follows the same four phases — tailored in scope, consistent in rigor.
Review your assay chemistry, sensor specs, detection modality, prior results, and reproducibility gaps. We come in with context, not assumptions.
Align on limit of detection, linearity, time-to-result, sample types, and acceptance criteria. Every decision gets documented before work begins.
Surface chemistry compatibility, blocking agents, drying protocols, environmental stability. We identify failure modes before they become prototype surprises.
Protocols, data summaries formatted for funding or regulatory review, and troubleshooting support through prototype integration. Transfer-ready by default.
Initial calls are 30 minutes and free. We'll tell you honestly if and how we can help.
Two Ph.D. founders. Hands-on labs. Real clinical data. No hand-waving.
Skip the ramp-up. We arrive with working assay chemistry and a short path to first decision-grade results.
Failure modes are identified before prototype stage. Bench-tested chemistry, not first-principles guesses.
Plans, results, and analysis that scientific reviewers and investment committees will believe.
Every protocol is written for CM handoff. No tolerance, yield, or scale surprises at the end.
We work alongside your team with full visibility into trade-offs — not as an external vendor.
No over-engineering. Engagements are sized for teams that need to ship, learn, and move fast.
PLACEHOLDER — Replace with a real client quote. Two to three outcome-focused sentences work best — specific results, not general praise.
Client Name
Title · Company
PLACEHOLDER — Replace with a second client quote, ideally from a different client type (e.g., VC firm vs. startup, or academic spinout vs. established IVD company).
Client Name
Title · Company